The COVID-19 vaccine that is being developed by AstraZeneca and Oxford university will resume trials after a break due to a reported side effect in a patient in UK.
University studies will be paused while it’s being investigated whether the adverse reaction was linked with the vaccine.
But on Saturday, the university said it had been deemed safe to continue.
Health Secretary Matt Hancock recieved the news that the test would continue.
“This pause shows we will always put safety first.
We will back our scientists to deliver an effective vaccine as soon as safely possible,” he added.
In addition the studies could now resume following guidance of an independent safety review committee and the UK regulator, the Medicines and Healthcare Products Regulatory Agency.